Lumexa Imaging (LMRI) vs TransMedics Group (TMDX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
TransMedics Group is the larger company by market cap ($2.74 billion vs $992.5 million), about 2.8 times the size. On valuation, Lumexa Imaging trades at a lower forward P/E (11.6x vs 35.0x for TransMedics Group).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LMRI | TMDX |
|---|---|---|
| Share price | $10.33 | $79.00 |
| Market cap | $992.45M | $2.74B |
| 1-day change | -2.46% | -2.55% |
| YTD return | -44.16% | -35.06% |
| 1-year return | — | -33.08% |
| 5-year return | — | +197.55% |
| P/E ratio (TTM) | — | 20.47 |
| Forward P/E | 11.61 | 35.05 |
| EPS (TTM) | $-0.37 | $3.86 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $605.49M |
| Revenue growth (YoY) | — | +37.13% |
| Net income (latest FY) | — | $190.29M |
| Gross margin | — | 59.92% |
| Operating margin | — | 17.93% |
| Net margin | — | 31.43% |
| 52-week high | $19.45 | $156.00 |
| 52-week low | $6.45 | $60.11 |
| Distance from 52-week high | -46.89% | -49.36% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +71.06% | +26.35% |
| Average volume | 430.76K | 820.41K |
| Shares outstanding | 96.07M | 34.68M |
| Employees | 5,000 | 898 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TransMedics Group is about 2.8 times larger than Lumexa Imaging by market value ($2.74B vs $992.45M).
About Lumexa Imaging
LMRI stock →Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.
Healthcare · Medical Devices · 5,000 employees
About TransMedics Group
TMDX stock →TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
Healthcare · Medical Devices · 898 employees
LMRI vs TMDX FAQ
Which is bigger, Lumexa Imaging or TransMedics Group?
TransMedics Group (TMDX) is larger, with a market capitalization of $2.74B compared with $992.45M for Lumexa Imaging (LMRI).
Are Lumexa Imaging and TransMedics Group in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.